Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease

Published:2011-10 Issue:4 Volume:10 Page:493-501
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Espino Alberto,Villagrán Andrea,Vollrath Valeska,Hanckes Paulina,Salas Roberto,Farah Andrea,Solís Nancy,Pizarro Margarita,Escalona Alex,Boza Camilo,Pérez Gustavo,Carrasco Gonzalo,Padilla Oslando,Francisco Miquel Juan,Nervi Flavio,C. Chavez-Tapia Norberto,Pablo Arab Juan,Álvarez-Lobos Manuel,Arrese Marco,Riquelme Arnoldo

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Reference43 articles.

1. The medical risks of obesity.;Pi-Sunyer;Postgrad Med,2009

2. Current concepts in the pathogenesis of nonalcoholic fatty liver disease.;Mendez-Sanchez;Liver Int,2007

3. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.;Targher;Semin Thromb Hemost,2009

4. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.;Meshkani;Clin Biochem,2009

5. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.;Targher;N Engl J Med,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasminogen Activator Inhibitor-1 Levels in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis;Journal of Gastrointestinal and Liver Diseases;2022-06-12

2. Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study;PLOS ONE;2021-11-23

3. Elevated expression of plasminogen activator inhibitor (PAI-1/SERPINE1) is independent from rs1799889 genotypes in arthrofibrosis;Meta Gene;2021-06

4. Disparities in End-Organ Care for Hispanic Patients with Kidney and Liver Disease: Implications for Access to Transplantation;Current Surgery Reports;2020-03

5. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases;Circulation Research;2020-02-28